BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 20225093)

  • 1. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
    Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
    BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.
    Buckley NE; Conlon SJ; Jirstrom K; Kay EW; Crawford NT; O'Grady A; Sheehan K; Mc Dade SS; Wang CW; McCance DJ; Johnston PG; Kennedy RD; Harkin DP; Mullan PB
    Cancer Res; 2011 Mar; 71(5):1933-44. PubMed ID: 21363924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma.
    Katoh I; Tsukinoki K; Hata RI; Kurata SI
    Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses.
    Napoli M; Deshpande AA; Chakravarti D; Rajapakshe K; Gunaratne PH; Coarfa C; Flores ER
    Cancer Res Commun; 2024 Feb; 4(2):264-278. PubMed ID: 38165157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of p63 isoforms and expansion of p63- and club cell secretory protein-positive epithelial cells in the lung as novel features of aging.
    Fukumoto J; Sidramagowda Patil S; Krishnamurthy S; Saji S; John I; Narala VR; Hernández-Cuervo H; Alleyn M; Breitzig MT; Galam L; Soundararajan R; Chaudhari UK; Hansen BC; Lockey RF; Kolliputi N
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C492-C508. PubMed ID: 30649915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63: a crucial player in epithelial stemness regulation.
    Li Y; Giovannini S; Wang T; Fang J; Li P; Shao C; Wang Y; ; Shi Y; Candi E; Melino G; Bernassola F
    Oncogene; 2023 Nov; 42(46):3371-3384. PubMed ID: 37848625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
    Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
    J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
    Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
    Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression.
    Mezzomo LC; Pesce FG; Marçal JM; Haag T; Ferreira NP; Lima JF; Leães CG; Oliveira MC; da Fonte Kohek MB
    Endocr Pathol; 2017 Mar; 28(1):13-21. PubMed ID: 28078618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.
    Stetsenko GY; Malekirad J; Paulson KG; Iyer JG; Thibodeau RM; Nagase K; Schmidt M; Storer BE; Argenyi ZB; Nghiem P
    Am J Clin Pathol; 2013 Dec; 140(6):838-44. PubMed ID: 24225752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
    Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 short isoforms are found in invasive carcinomas only and not in benign breast conditions.
    de Biase D; Morandi L; Degli Esposti R; Ligorio C; Pession A; Foschini MP; Eusebi V
    Virchows Arch; 2010 Apr; 456(4):395-401. PubMed ID: 20225093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
    Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
    Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
    Alkhayyat R; Abbas A; Quinn CM; Rakha EA
    Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.